Roberts Glore & CO Inc Astrazeneca PLC Transaction History
Roberts Glore & CO Inc
- $328 Million
- Q2 2024
A detailed history of Roberts Glore & CO Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Roberts Glore & CO Inc holds 4,646 shares of AZN stock, worth $385,943. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,646
Previous 4,779
2.78%
Holding current value
$385,943
Previous $323,000
12.07%
% of portfolio
0.11%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...